Correlation Between Valneva SE and UroGen Pharma

Can any of the company-specific risk be diversified away by investing in both Valneva SE and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Valneva SE ADR and UroGen Pharma, you can compare the effects of market volatilities on Valneva SE and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and UroGen Pharma.

Diversification Opportunities for Valneva SE and UroGen Pharma

0.67

Correlation Coefficient

Valneva SE  UroGen Pharma

Poor diversification

The 3 months correlation between Valneva and UroGen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of Valneva SE i.e., Valneva SE and UroGen Pharma go up and down completely randomly.

Pair Corralation between Valneva SE and UroGen Pharma

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the UroGen Pharma. In addition to that, Valneva SE is 1.15 times more volatile than UroGen Pharma. It trades about -0.64 of its total potential returns per unit of risk. UroGen Pharma is currently generating about 0.15 per unit of volatility. If you would invest  1,193  in UroGen Pharma on September 4, 2024 and sell it today you would earn a total of  95.00  from holding UroGen Pharma or generate 7.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Valneva SE ADR  vs.  UroGen Pharma

Valneva SE ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

UroGen Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days UroGen Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, UroGen Pharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Valneva SE and UroGen Pharma

The main advantage of trading using opposite Valneva SE and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.

The idea behind Valneva SE ADR and UroGen Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.